-
Hispanics and CVD: Country of Origin Matters
Hispanic, Latino -- the lingo and migratory patterns have changed over time, which is why clinicians should not assume that all patients share the same risk profiles, cautions Ileana Piña, MD.
Experts And Viewpoints, September 22, 2020
-
SGLT2 Inhibitors in HFrEF: Putting EMPEROR-Reduced in Context
Dr Ileana Piña asks the lead investigator how his trial on empagliflozin in HFrEF compares with DAPA-HF. They speculate on the likely mechanism of action of these relatively new drugs.
Experts And Viewpoints, August 31, 2020
-
Cookbook Medicine Won't Cut It With New Drugs for HFrEF
The plethora of new drugs means one size will not fit all patients with HFrEF. Clinicians will have to tailor their strategies, says Ileana Pina, MD.
Experts And Viewpoints, August 20, 2020
-
Clinical Trials and the COVID-19 Conundrum
The pandemic has critically altered current clinical research. Dr Ileana Pina implores researchers to work together and 'not stop all the good work that is being done.'
Experts And Viewpoints, June 01, 2020
-
VICTORIA PIs See Vericiguat as 'A Win' for High-Risk HFrEF
Ileana Piña gets the details on vericiguat, an investigational guanylate cyclase stimulator that may open up a new treatment pathway for high-risk heart failure.
Experts And Viewpoints, May 13, 2020
-
Is Hyperkalemia Always Bad in Patients With HF?
Dr Ileana Piña discusses facilitating RAAS inhibitors with potassium binders for patients with renal dysfunction.
Experts And Viewpoints, March 12, 2020
-
Do More HF Drugs Make It the Best or the Worst of Times?
New HF treatment regimens keep piling new drugs onto the old ones, making it less likely that patients will be able to adhere to the regimen, says Dr Ileana Piña.
Experts And Viewpoints, March 03, 2020
-
Controversies in Cardiogenic Shock
Dr Ileana Piña discusses controversies surrounding cardiogenic shock, including data presented at the AHA Scientific Sessions 2019.
Experts And Viewpoints, January 23, 2020
-
Making Room for New Drugs for Heart Failure
Drs Ileana Piña and Mary Walsh discuss the latest HF updates from the American Heart Association Scientific Sessions and ask where dapagliflozin and sacubitril/valsartan will fit in the armamentarium.
Experts And Viewpoints, November 26, 2019
-
PROVE-HF Cracks the 'Holy Grail' of Cardiac Remodeling in HFrEF
Ileana Piña, MD speaks with lead author Jim Januzzi, MD, about the path to PROVE-HF and how sacubitril/valsartan benefits real-world patients with heart failure with reduced ejection fraction.
Experts And Viewpoints, October 07, 2019
-
PARAGON-HF: Is There a Role for the ARNI in HFpEF?
Ileana Piña quizzes investigator Burkert Pieske on the findings for sacubitril/valsartan in patients with HFpEF, including exploratory subgroup analyses and use of mineralocorticoid-receptor antagonists.
Experts And Viewpoints, September 16, 2019
-
Do We Need to Rethink Acute Heart Failure?
Patients with acute heart failure may comprise more than one single group, says Dr Piña.
Experts And Viewpoints, July 19, 2019
-
'Think Twice' Before Stopping Heart Failure Meds
Positive effects can be lost and patient outcomes adversely affected if heart failure drugs are stopped. Dr Pina reviews new evidence.
Experts And Viewpoints, April 29, 2019
-
Hopeful Heart: Hope for Improving QoL in Depressed HF Patients
'Depression kills,' says Bruce Rollman, MD, the lead author of the Hopeful Heart study. Screening can identify HF patients at risk for depression and improve outcomes.
Experts And Viewpoints, April 01, 2019
-
SGLT2 Inhibitors to Prevent HF: Time to Get More Proactive?
Drs Pi?a and Butler discuss the accumulating 'consistent' data regarding SGLT2 inhibitors for prevention of heart failure in patients with diabetes.
Experts And Viewpoints, February 04, 2019
-
Sodium Restriction in HF: Take It With a Grain of Salt?
Despite wide acceptance, evidence to support low-sodium diets is lacking. Until we know more, keep dietary recommendations simple, says Ileana Piña, MD.
Experts And Viewpoints, January 10, 2019
-
Does PIONEER-HF Warrant Acute HF Indication for ARNI?
Drs Pina and Butler discuss the new findings of PIONEER-HF, a trial evaluating angiotensin-neprilysin inhibition in acute heart failure.
Experts And Viewpoints, December 13, 2018
-
PIONEER: A Role for ARNI in Stabilized Acute HF?
Sacubitril/valsartan (Entresto) was studied in patients with acute decompensated heart failure in the PIONEER HF Trial. Dr Pi?a gets the details from lead investigator Eric Velazquez.
Experts And Viewpoints, November 29, 2018
-
Teaming Up to Prevent Heart Disease in People With Diabetes
The American Heart Association and American Diabetes Association are collaborating to improve cardiovascular care of patients with diabetes. Drs Ileana Piña and Stacey Rosen discuss the initiative.
Experts And Viewpoints, October 15, 2018
-
Coronary Microvascular Dysfunction: Common Finding in HFpEF
Dr Ileana Pi?a discusses coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction with PROMIS-HFpEF investigator Dr Carolyn Lam.
Experts And Viewpoints, September 25, 2018
